Non-small cell lung cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Total 963 patients registered for the JCOG0707: "phase III Study of adjuvant chemotherapy for the patients resected pathological stage I (T1>2cm) non- small cell lung cancer"
Exclusion criteria
Exclusion criteria: Not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence-free survival, site of recurrence, cumulative incidence of secondary cancer, cumulative incidence of death from primary lung cancer, cumulative incidence of all causes of deaths (deaths from cancers and deaths from non-cancer causes) | — |
Countries
Japan
Contacts
JCOG0707A1 Coordinating Office National Cancer Center Hospital, Department of Thoracic Surgery